A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results.
Saved in:
| Title: | A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. |
|---|---|
| Authors: | Wein A; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Stoehr R; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Kersting S; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.; Department of Surgery, University of Greifswald, Greifswald, Germany., Siebler J; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Merkel S; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Busse D; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Wolff K; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Ostermeier N; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Neufert C; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Vitali F; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Eckstein M; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Roth JP; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Anhut P; Medical Practice of Oncology, Kronach, Germany., Schreiner W; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Uder M; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Hartmann A; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Neurath MF; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Grützmann R; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. |
| Source: | Oncology [Oncology] 2022; Vol. 100 (1), pp. 1-11. Date of Electronic Publication: 2021 Oct 20. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1423-0232 |
|---|---|
| DOI: | 10.1159/000519252 |
